Literature DB >> 9731985

Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by "proteome" technologies.

C P McAtee1, K E Fry, D E Berg.   

Abstract

BACKGROUND: There is great interest in characterizing the proteins of the gastric pathogen, Helicobacter pylori, especially those proteins to which humans respond immunologically. Such proteins have potential importance in diagnosis and vaccine development.
METHODS: Two-dimensional gel electrophoresis in combination with Western blotting was used to separate and identify potential antigens of Helicobacter pylori strain Z-170. Proteins found to be reactive with pooled sera from 14 infected patients were individually digested in situ with endoproteinase Lys-C, and the resulting fragments were analyzed by matrix assisted laser desorption time-of-flight mass spectrometry (MALDI-TOF MS).
RESULTS: Over 20 proteins were reactive in Western blots with pooled sera from 14 infected patients. The mass spectral data was compared with predictions from the H. pylori genome DNA sequence. Each of the 20 proteins was readily identified.
CONCLUSIONS: We propose that this "proteome" approach for identification of previously unknown proteins will be useful in examining regulation of H. pylori gene expression and protein localization in the development of improved serologic tests to detect and monitor H. pylori infection. This approach will also be useful for identifying potential targets for antimicrobial or vaccine development for H. pylori and other pathogens whose genomes have been sequenced.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731985

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  8 in total

1.  Proteome analysis of secreted proteins of the gastric pathogen Helicobacter pylori.

Authors:  Dirk Bumann; Sevil Aksu; Meike Wendland; Katharina Janek; Uschi Zimny-Arndt; Nicolas Sabarth; Thomas F Meyer; Peter R Jungblut
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

2.  Clustering of clinical strains of Helicobacter pylori analyzed by two-dimensional gel electrophoresis.

Authors:  H Enroth; T Akerlund; A Sillén; L Engstrand
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 3.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

4.  Complexomics study of two Helicobacter pylori strains of two pathological origins: potential targets for vaccine development and new insight in bacteria metabolism.

Authors:  Cédric Bernarde; Philippe Lehours; Jean-Paul Lasserre; Michel Castroviejo; Marc Bonneu; Francis Mégraud; Armelle Ménard
Journal:  Mol Cell Proteomics       Date:  2010-07-07       Impact factor: 5.911

5.  A comparison of murine and human immunoproteomes of Helicobacter pylori validates the preclinical murine infection model for antigen screening.

Authors:  Dirk Bumann; Petra Holland; Frank Siejak; Jan Koesling; Nicolas Sabarth; Stefanie Lamer; Ursula Zimny-Arndt; Peter R Jungblut; Thomas F Meyer
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Proteomic insights into Helicobacter pylori coccoid forms under oxidative stress.

Authors:  Hao Zeng; Gang Guo; Xu Hu Mao; Wen De Tong; Quan Ming Zou
Journal:  Curr Microbiol       Date:  2008-06-28       Impact factor: 2.188

7.  A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi.

Authors:  Alan G Barbour; Algimantas Jasinskas; Matthew A Kayala; D Huw Davies; Allen C Steere; Pierre Baldi; Philip L Felgner
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

8.  Proteomic characterization of Helicobacter pylori CagA antigen recognized by child serum antibodies and its epitope mapping by peptide array.

Authors:  Junko Akada; Masumi Okuda; Narumi Hiramoto; Takao Kitagawa; Xiulian Zhang; Shuichi Kamei; Akane Ito; Mikiko Nakamura; Tomohisa Uchida; Tomoko Hiwatani; Yoshihiro Fukuda; Teruko Nakazawa; Yasuhiro Kuramitsu; Kazuyuki Nakamura
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.